Within one year of enactment, H.R. 3490 would direct the Government Accountability Office to report on esophageal cancer. The report would include an evaluation of the cost of health care spending related to esophageal cancer under the Federal Employee Health Benefits Program and the frequency with which people who are covered under that program and who have a high risk for esophageal cancer are screened according to established guidelines.
Based on the cost of similar reports, CBO estimates that implementing the bill would cost less than $500,000 over the 2025-2030 period. Any spending would be subject to the availability of appropriated funds.
The CBO staff contact for this estimate is David Rafferty. The estimate was reviewed by H. Samuel Papenfuss, Deputy Director of Budget Analysis.
